Real-time PCR systems that fully integrate with cloud computing technology are the latest additions to the QuantStudio portfolio from Thermo Fisher Scientific.
The Applied Biosystems QuantStudio 3 and QuantStudio 5 Real-Time PCR systems are designed to enable multi-institutional work across geographically dispersed teams.
Designed for low- to mid-throughput laboratories conducting real-time PCR experiments, the systems are the first to connect to the Thermo Fisher Cloud computing platform, allowing applied and clinical researchers to learn, analyse, share, collaborate, and obtain support within a single platform.
Researchers worldwide can collaborate online in real-time, and access their data wherever and whenever necessary.
Laboratories can also share experimental conditions and results with their partners, while providing a uniform experience for every user, and helping minimise training and errors.
“The QuantStudio 3 and 5 systems have been brought to market by a team with a heritage of developing the most advanced qPCR platforms,” said Chris Linthwaite, president, Genetic Sciences at Thermo Fisher Scientific.
“By linking technologies to a common computing platform, researchers working to control an outbreak, for example, can leverage laboratories across the world to identify virus strains from various hot zones, perform screening of the strains and monitor strain mutation in real time.”
With the Applied Biosystems QuantStudio 3 and QuantStudio 5 Real-Time PCR systems hosted on AWS, these PCR systems benefit from the inherent security of the AWS Cloud.
The AWS Cloud infrastructure is architected for flexibility and security, and provides an extremely scalable, highly reliable platform that enables customers to deploy applications and data quickly and securely.
Researchers using the PCR systems can access their work any time they have an Internet connection, without the need for subscription software.
“Thermo Fisher Scientific’s use of AWS to power their real-time collaboration systems enables secure access to data whenever necessary, anywhere in the world, and is a great example of innovative use of the AWS Cloud,” said Steve Halliwell, director, Healthcare & Life Sciences, Amazon Web Services.
“The security and privacy of customers’ data are foundational principles at AWS, and we are continuously innovating to allow customers to build applications that meet evolving security and compliance requirements across our global footprint.”
The new instruments are designed to seamlessly integrate with existing analysis workflows, syncing with next-generation sequencing (NGS), capillary electrophoresis (CE) and qPCR applications to create a customised data ecosystem.
Interactive touch screen controls allow scientists to directly manage experiments with intuitive commands.
As with the existing QuantStudio 6, 7, and 12K Flex instruments, the 3 and 5 include the state-of-the-art Thermo Scientific OptiFlex white LED optical system and VeriFlex thermal technology.
Applied Biosystems QuantStudio 3 and QuantStudio 5 Real-Time PCR systems are for research use only; not intended for diagnostic purposes.
